|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chung Moh M, Hoon Lee L and Shen S:
Cloning and characterization of hepaCAM, a novel Ig-like cell
adhesion molecule suppressed in human hepatocellular carcinoma. J
Hepatol. 42:833–841. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moh MC, Zhang T, Lee LH and Shen S:
Expression of hepaCAM is downregulated in cancers and induces
senescence-like growth arrest via a p53/p21-dependent pathway in
human breast cancer cells. Carcinogenesis. 29:2298–2305. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu B, He Y, Wu X, Luo C, Liu A and Zhang
J: Exploration of the correlations between interferon-γ in patient
serum and HEPACAM in bladder transitional cell carcinoma, and the
interferon-γ mechanism inhibiting BIU-87 proliferation. J Urol.
188:1346–1353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xun C, Luo C, Wu X, Zhang Q, Yan L and
Shen S: Expression of hepaCAM and its effect on proliferation of
tumor cells in renal cell carcinoma. Urology. 75:828–834. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang QL, Luo CL, Wu XH, Wang CY, Xu X,
Zhang YY, Liu Q and Shen SL: HepaCAM induces G1 phase arrest and
promotes c-Myc degradation in human renal cell carcinoma. J Cell
Biochem. 112:2910–2919. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song X, Wang Y, Du H, Fan Y, Yang X, Wang
X, Wu X and Luo C: Overexpression of HepaCAM inhibits cell
viability and motility through suppressing nucleus translocation of
androgen receptor and ERK signaling in prostate cancer. Prostate.
74:1023–1033. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Chen E, Tang M, Yang X, Wang Y,
Quan Z, Wu X and Luo C: The SMAD2/3 pathway is involved in
hepaCAM-induced apoptosis by inhibiting the nuclear translocation
of SMAD2/3 in bladder cancer cells. Tumour Biol. 37:10731–10743.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wen S, Chang HC, Tian J, Shang Z, Niu Y
and Chang C: Stromal androgen receptor roles in the development of
normal prostate, benign prostate hyperplasia, and prostate cancer.
Am J Pathol. 185:293–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Scher HI and Sawyers CL: Biology of
progressive, castration-resistant prostate cancer: Directed
therapies targeting the androgen-receptor signaling axis. J Clin
Oncol. 23:8253–8261. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Taplin ME and Balk SP: Androgen receptor:
A key molecule in the progression of prostate cancer to hormone
independence. J Cell Biochem. 91:483–890. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Y, Clegg NJ and Scher HI:
Anti-androgens and androgen-depleting therapies in prostate cancer:
New agents for an established target. Lancet Oncol. 10:981–991.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Attard G, Cooper CS and de Bono JS:
Steroid hormone receptors in prostate cancer: A hard habit to
break? Cancer Cell. 16:458–462. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dehm SM and Tindall DJ: Androgen receptor
structural and functional elements: Role and regulation in prostate
cancer. Mol Endocrinol. 21:2855–2863. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Knudsen KE and Scher HI: Starving the
addiction: New opportunities for durable suppression of AR
signaling in prostate cancer. Clin Cancer Res. 15:4792–4798. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Adam SA and Gerace L: Cytosolic proteins
that specifically bind nuclear location signals are receptors for
nuclear import. Cell. 66:837–847. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rexach M and Blobel G: Protein import into
nuclei: Association and dissociation reactions involving transport
substrate, transport factors, and nucleoporins. Cell. 83:683–692.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weis K, Dingwall C and Lamond AI:
Characterization of the nuclear protein import mechanism using Ran
mutants with altered nucleotide binding specificities. EMBO J.
15:7120–7128. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sanda MG, Cadeddu JA, Kirkby E, Chen RC,
Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH,
Makarov DV, et al: Clinically localized prostate cancer:
AUA/ASTRO/SUO Guideline. Part I: Risk stratification, shared
decision making, and care options. J Urol. 199:683–690. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Wu X, Ou L, Yang X, Wang X, Tang
M, Chen E and Luo C: PLCepsilon knockdown inhibits prostate cancer
cell proliferation via suppression of Notch signalling and nuclear
translocation of the androgen receptor. Cancer Lett. 362:61–69.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Q, Luo C, Wu X, Du H, Song X and Fan
Y: hepaCAM and p-mTOR closely correlate in bladder transitional
cell carcinoma and hepaCAM expression inhibits proliferation via an
AMPK/mTOR dependent pathway in human bladder cancer cells. J Urol.
190:1912–1918. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang L, Hou Y, Sun Y, Zhao L, Tang X, Hu
P, Yang J, Zeng Z, Yang G, Cui X and Liu M: c-Ski activates
cancer-associated fibroblasts to regulate breast cancer cell
invasion. Mol Oncol. 7:1116–1128. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Becker KF, Rosivatz E, Blechschmidt K,
Kremmer E, Sarbia M and Höfler H: Analysis of the E-cadherin
repressor Snail in primary human cancers. Cells Tissues Organs.
185:204–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bennett NC, Gardiner RA, Hooper JD,
Johnson DW and Gobe GC: Molecular cell biology of androgen receptor
signalling. Int J Biochem Cell Biol. 42:813–827. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taplin ME and Balk SP: Androgen receptor:
A key molecule in the progression of prostate cancer to hormone
independence. J Cell Biochem. 91:483–490. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Quan Z, He Y, Luo C, Xia Y, Zhao Y, Liu N
and Wu X: Interleukin 6 induces cell proliferation of clear cell
renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent
up-regulation of DNMT1 or DNMT3b. Cell Signal. 32:48–58. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moh MC, Zhang C, Luo C, Lee LH and Shen S:
Structural and functional analyses of a novel ig-like cell adhesion
molecule, hepaCAM, in the human breast carcinoma MCF7 cells. J Biol
Chem. 280:27366–27374. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Geng HT, Cao RJ, Cheng L and Liu CY:
Overexpression of hepatocyte cell adhesion molecule (hepaCAM)
inhibits the proliferation, migration, and invasion in colorectal
cancer cells. Oncol Res. 25:1039–1046. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du Z, Li L, Sun W, Wang X, Zhang Y, Chen
Z, Yuan M, Quan Z, Liu N, Hao Y, et al: HepaCAM inhibits the
malignant behavior of castration-resistant prostate cancer cells by
downregulating Notch signaling and PF-3084014 (a γ-secretase
inhibitor) partly reverses the resistance of refractory prostate
cancer to docetaxel and enzalutamide in vitro. Int J Oncol.
53:99–112. 2018.PubMed/NCBI
|
|
31
|
Bluemn EG and Nelson PS: The
androgen/androgen receptor axis in prostate cancer. Curr Opin
Oncol. 24:251–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ardiani A, Gameiro SR, Kwilas AR, Donahue
RN and Hodge JW: Androgen deprivation therapy sensitizes prostate
cancer cells to T-cell killing through androgen receptor dependent
modulation of the apoptotic pathway. Oncotarget. 5:9335–9348. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shank LC, Kelley JB, Gioeli D, Yang CS,
Spencer A, Allison LA and Paschal BM: Activation of the
DNA-dependent protein kinase stimulates nuclear export of the
androgen receptor in vitro. J Biol Chem. 283:10568–10580. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Matchett KB, McFarlane S, Hamilton SE,
Eltuhamy YS, Davidson MA, Murray JT, Faheem AM and El-Tanani M: Ran
GTPase in nuclear envelope formation and cancer metastasis. Adv Exp
Med Biol. 773:323–351. 2014. View Article : Google Scholar : PubMed/NCBI
|
